valor de las acciones
Competidores
| Simbolo bursátil | Precio | Pronóstico 1A | Pronóstico 2A | Cap. Mercado | Div Yld | Tasa de crecimiento |
|---|---|---|---|---|---|---|
|
NasdaqGS:IDXX
IDEXX Laboratories
|
543.45 | -1.93% | 11.41% | 44,882.08 | 0% | 18.75% |
|
NYSE:IQV
IQVIA Holdings
|
231.18 | 17.25% | 34.12% | 42,121 | 0% | 12.94% |
|
NasdaqGS:ICLR
ICON Public
|
314.72 | 8.72% | 23.9% | 26,022.25 | 0% | 16% |
|
ENXTBR:ARGX
argenx
|
339.90 | 0% | 0% | 20,200.62 | 0% | 0% |
|
CPSE:GMAB
Genmab A/S
|
2041.00 | 64.8% | 124.4% | 131,830.48 | 0% | 22.71% |
|
XTRA:SRT3
Sartorius
|
268.50 | 29.39% | 60.08% | 16,669.07 | 0.27% | 14.01% |
|
NYSE:LH
Laboratory Corp of America Holdings
|
210.59 | -11.18% | -1.66% | 17,751.4 | 1.35% | 4.24% |
|
SWX:SGSN
SGS
|
80.72 | 887.92% | 968.45% | 15,278.36 | 3.95% | -1.74% |
|
NYSE:DGX
Quest Diagnostics
|
144.34 | -10.75% | -2.08% | 16,034.96 | 2.11% | 6.66% |
|
ENXTPA:BVI
Bureau Veritas
|
27.52 | 4.59% | 15.11% | 12,884.95 | 3.01% | 5.76% |
|
NasdaqGS:MEDP
Medpace Holdings
|
393.30 | -18.97% | -3.47% | 12,340.6 | 0% | 25.99% |
|
ENXTPA:ERF
Eurofins Scientific
|
58.26 | 14% | 29.25% | 11,046.73 | 0.84% | 7.46% |
|
NYSE:CRL
Charles River Laboratories International
|
221.61 | 15.62% | 31.45% | 11,815.07 | 0% | 12.09% |
|
BIT:REC
Recordati Industria Chimica e Farmaceutica
S.p.A. |
51.20 | 18.28% | 30.99% | 10,363.08 | 2.36% | 10.99% |
|
LSE:ITRK
Intertek Group
|
49.54 | 5,998.22% | 6,510.77% | 8,150.85 | 2.26% | 2.41% |
|
NYSE:CTLT
Catalent
|
55.37 | -57.27% | -6.76% | 10,100.49 | 0% | -10.41% |
|
ASX:SHL
Sonic Healthcare
|
26.63 | 6.42% | 29.07% | 12,778.75 | 3.85% | 5.68% |
|
SWX:BANB
Bachem Holding
|
90.60 | -6.38% | 15.44% | 6,252.8 | 0.87% | -15.25% |
|
CPSE:ZEAL
Zealand Pharma A/S
|
600.00 | 0% | 0% | 38,517.01 | 0% | 0% |
|
LSE:HIK
Hikma Pharmaceuticals PLC
|
19.78 | 25.31% | 38.17% | 4,424.39 | 2.87% | 10.04% |
